ArticlePLOS global public health2025
Post-discharge mortality in suspected pediatric sepsis: Insights from rural and urban healthcare settings in Rwanda.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Validation of a risk-prediction model for pediatric post-discharge mortality after hospital admission for infection in Rwanda: A prospective cohort study.PLOS global public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Post-discharge death is a key contributor to pediatric mortality in sub-Saharan Africa. To address this period's morbidity and mortality, evidence is needed to inform resource prioritization and policy development. No studies have been conducted in Rwanda, limiting understanding of post-discharge mortality. This study aimed to determine the incidence of and risk factors for post-discharge mortality among children under five admitted with suspected sepsis in Rwanda's rural and urban healthcare settings. We conducted a prospective, epidemiologic cohort study of post-discharge mortality in children ages 0-60 months admitted for suspected or confirmed infection in two Rwandan hospitals, one rural (Ruhengeri) and one urban (Kigali), from May 2022 to February 2023. We collected clinical, laboratory, and sociodemographic data on admission and follow-up vital statistics at 2-, 4-, and 6-months post-discharge. Of 1218 children enrolled, 115 (9.4%) died, with half in-hospital (n = 57, 4.7%) and half post-discharge (n = 58, 4.7%). Post-discharge mortality was lower in the 6-60-month cohort (n = 30, 3.5%) than in the 0-6-month cohort (10%) and higher in Kigali (n = 37, 10.3%) vs. Ruhengeri (n = 21, 2.7%). Median time to post-discharge death was 38 days (IQR: 16-97.5) in the 0-6-month cohort and 33 days (IQR: 12-76) in the 6-60-month cohort. In the 0-6 months' cohort, malnutrition (weight-for-age z-score < -3) increased the odds of post-discharge death (aOR 3.31, 95% CI 1.28-8.04), while higher maternal education was protective (aOR 0.15, 95% CI 0.03-0.85). Significant factors in the 6-60-month cohort included an abnormal Blantyre Coma Scale (aOR 3.28, 95% CI 1.47-7.34), travel time to care >;1 hour (aOR 3.54, 95% CI 1.26-9.93), and referral for higher care (aOR 4.13, 95% CI 1.05-16.27). Children aged <2 months within the 0-6 month cohort exhibited the highest cumulative mortality risk. Post-discharge mortality among Rwandan children remains a challenge, requiring interventions like caregiver counselling, follow-up visits, and community health worker monitoring to reduce mortality rates.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.